Neuro Psychiatry

Specialty neurological and psychiatric formulations for epilepsy, depression, anxiety, Alzheimer's, and neuropathic pain.

10M+

Epilepsy patients in India

56M

Depression cases in India

38M

Anxiety disorder patients

70%

Treatment gap in rural India

Clinical Overview

The Neuro Psychiatry challenge in India

Neurological and psychiatric disorders are among the most under-diagnosed and under-treated conditions in India, carrying an enormous treatment gap — particularly in rural and semi-urban populations. Epilepsy alone affects over 10 million Indians, yet fewer than half receive consistent medication.

Q-Check's Neuro Psychiatry range is formulated for the complex management demands of neurologists, psychiatrists, and neuropsychiatrists. Through our Space Division, these specialty molecules reach the right practitioners via dedicated, highly trained medical representatives with deep therapeutic area knowledge.

Conditions Covered